NRT Smoking Cessation Aids in New Zealand

Date: November 30, 2017
Pages: 19
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N024A5CE75BEN
Leaflet:

Download PDF Leaflet

The main driver of growth in NRT smoking cessation aids is the campaign for a Smokefree New Zealand by the year 2025, which aims to achieve under 5% smoking prevalence by 2025. This initiative led to continued government-enforced excise tax rises, legislated until the year 2020. In addition, those who want to quit smoking are encouraged to move to NRT smoking cessation aids, which are government-funded through Quitline. A registered participant can get a four-week supply of patches, lozenges or...

Euromonitor International's NRT Smoking Cessation Aids in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the NRT Smoking Cessation Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Government Policy of Smokefree New Zealand
the Threat From E-cigarettes
Gum Remains the Most Accessible Product
Competitive Landscape
Lack of Competition Due To the Government-funded Programme
Two Smaller Players Far Behind
Competition Likely From E-cigarettes
Category Indicators
  Table 1 Number of Smokers by Gender 2012-2017
Category Data
  Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
  Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
  Table 4 Sales of NRT Gum by Flavour: % Value 2012-2017
  Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2013-2017
  Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2014-2017
  Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
  Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Executive Summary
Consistent Growth Overall
Age Segmentation Continues
Hybrid Product Developments
Internet Sales Expected To Increase
Modest Growth Expected Over the Forecast Period
Market Indicators
  Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 10 Life Expectancy at Birth 2012-2017
Market Data
  Table 11 Sales of Consumer Health by Category: Value 2012-2017
  Table 12 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 13 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 14 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 17 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 18 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2016-2017
Sources
  Summary 2 Research Sources












Skip to top


NRT Smoking Cessation Aids in Lithuania US$ 990.00 Apr, 2013 · 21 pages
NRT Smoking Cessation Aids - Malaysia US$ 900.00 May, 2010 · 33 pages
NRT Smoking Cessation Aids in Mexico US$ 990.00 Oct, 2017 · 18 pages
NRT Smoking Cessation Aids in Morocco US$ 990.00 Oct, 2017 · 16 pages
NRT Smoking Cessation Aids - Philippines US$ 990.00 Mar, 2010 · 36 pages

Ask Your Question

NRT Smoking Cessation Aids in New Zealand
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: